Business Wire

JTB Group Unveils its Long-Term Vision “OPEN FRONTIER 2035”

3.2.2026 14:00:00 CET | Business Wire | Press Release

Share

JTB Group has unveiled “OPEN FRONTIER 2035,” its long-term vision for the next decade. The vision positions JTB as a frontier (leading-edge) enterprise that brings together people, places, businesses, and possibilities to create connections and generate new value for society. By pioneering a new era of Designing Human Moments, we will harness our expertise and insights to connect, create, and contribute to the world—enriching people’s lives with excitement and contentment.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260203174455/en/

JTB Group's Desired Vision for 2035

Our Source of Value is the Power to Create Connections

JTB Group has positioned “Intelligence that Creates Connections” as the core of its competitive advantage. Insight and expertise—when combined and continuously enhanced—will enable the Group to create meaningful connections by bringing together people, places, businesses, and possibilities, thereby generating new value for society.

Four Keys to Transforming Our Vision

In line with its aspiration to become a frontier enterprise, JTB Group will leverage the insights and expertise cultivated over its 114-year history to maximize its ability to create connections, address social challenges, and help shape a sustainable future for the global tourism industry. To realize its desired vision, JTB Group will drive transformation across four key focus areas. The focus of each of these will be as follows:

  • Global
    Expansion ofbusiness activities across the world
    Creating global appeal with a “glocal” approach (a focus on unique local market requirements that will resonate with customers who have a presence in multiple countries)
  • Business Model
    Shift to a business ownership model by owning IP and assets including real estate
    Redesign of our revenue model to combine once-off and recurring revenues
  • Information / Data
    Building an AI-powered information platform to evolve insights
    Organizing and clarifying information to make insights more explicit
  • Culture
    Embracing diversity and harmony

Business Strategy Segments Based on Global Market / Customer Focus

To drive its transformation, we have established strategic business segments that integrate what we call Global Tourism Intelligence.

  • Global Area Solution
    We will elevate overall regional value through investment in, and the provision of solutions to, local governments, Destination Management Organizations, and tourism operators.
  • Global Tourist Solution
    We will leverage marketing capabilities to propose optimal travel experience for each individual traveler.
  • Global Business Solution
    We will co-create high-return solutions for corporate and academic sector clients leveraging our planning and production capabilities.
  • Global Tourism Intelligence
    We will enhance the value we create for tourism industry stakeholders by providing marketing solutions through the media and via events.

Key 2035 Financial Targets

We have set clear long‑term targets to scale our business and strengthen our profitability. On a management accounting basis, we aim to increase transaction volume, expand gross profit, and lift margins materially by FY2035, as follows:

  • FY2024 Results (management accounting)
    - Revenue: ¥1,683.8 trillion
    - Gross profit: ¥293.7 billion
    - Operating profit: ¥14.9 billion
    - Gross operating profit ratio: 5.0%
  • FY2035 Targets (management accounting)
    - Revenue: ¥2,500 trillion
    - Gross profit: ¥500 billion
    - Operating profit: ¥75 billion
    - Gross operating profit ratio: 15%

In order to achieve these key financial targets, we have established the following basic policies to maximize corporate value over the medium- to long term and achieve sustainable growth. We will:

  1. Generate financial capacity to allow investment in growth and the formation of high-quality assets, establishing a virtuous cycle of growth.
  2. Enhance creditworthiness and financing capability by improving our corporate value.
  3. Prepare for contingencies by promptly securing a level of net assets capable of withstanding foreseeable losses, thereby helping to ensure business continuity.

Transforming Our Business Portfolio (Ratio Targets)

To realize its Vision, we will advance its business, investment, and talent portfolios in an integrated manner, deploying management resources efficiently and with agility in order to achieve sustainable growth and enhance corporate value. By addressing both growth and profitability across each business area, we aim to achieve the following key financial targets:

  • Global business ratio
    Baseline FY2024: Global 14% / Japan 86% (includes Japan inbound)
    Target FY2035: Global 50% / Japan 50%
  • People-traffic business dependency
    Baseline FY2024: 20% not dependent on people traffic / 80% dependent
    Target FY2035: 25% not dependent / 75% dependent
  • Revenue categories
    Baseline FY2024: 11% recurring / 89% once-off
    Target FY2035: 30% recurring / 70% once-off
  • Sustainability endorsement (of partner base)
    Policy establishment: June 2025—Sustainable Transaction Policy
    Target FY2035: 63% of business partners implementing sustainability initiatives

Investment Strategy: Establishing a Cycle for Sustainable Growth

Centering on focused investment in premium assets—business assets, intellectual property/rights, and human capital—we will establish a cycle of development > revenue growth > priority reinvestment, upgrading assets through our business activities to generate additional cash flow. Leveraging IP rights to secure competitive advantage and enhancing our employee skills and motivation levels will allow us to create sustainable value through increased investment in both business assets and in human capital.

Talent Strategy, Culture

We will implement borderless ways of working that are unconstrained by time, place, or organizational boundaries; support career design aligned with each employee’s personal “Will;” and make skills and experience visible to enable effective career matching. Through these efforts, we will enable employees with diverse talents worldwide to co-create value on a global stage, continually generating new connections across the JTB Group.

Sustainability

To advance our corporate mission, JTB Group has defined three material topics— “Enriching the Human Experience” “Nurturing Our Surroundings” and “Engaged Partnering”—alongside eight sub-material topics. We are implementing initiatives that maximize the positive impact arising from connection and minimize any negative impact.

In June 2025, we established a Sustainable Transaction Policy, setting a 2035 target for 63 percent of our business transactions to be with partners pursuing sustainability initiatives. We are also enhancing accessibility across our websites and digital channels to offer customers choices of products and services grounded in sustainability.

Establishment of the JTB Social Commitment Program “Mirai Exchange Creation Fund”

We will increase its pursuit of CSR initiatives that help address social challenges, and, as part of these efforts, we will establish the JTB Social Commitment Program: Mirai Exchange Creation Fund in April 2026. The Fund will provide ongoing support—through donations and grants—for activities that preserve and protect local communities. Specifically, the Fund will support the protection and utilization of historical buildings and intangible cultural assets such as festivals, the restoration and conservation of natural environments, and measures against overtourism—helping regions cultivate value more sustainably.

Looking Ahead

As AI agents create new businesses and society undergoes profound transformation, the value of connections will continue to grow. Building on this momentum, JTB will deepen and broaden the impact of connections, expanding the potential of the tourism industry while evolving as a pioneering enterprise that creates new value for society. Through co-creation with partners who bring diverse technologies, insights, and networks, we will help realize a sustainable and prosperous future.

About JTB Corp.

JTB is one of Japan's leading travel solutions providers, offering a diverse range of services and products tailored to meet the evolving needs of its clients. With a rich history dating back to 1912, JTB has consistently adapted and innovated to maintain its position at the forefront of the industry. From individual travel and the promotion of regional tourism to business meetings and sporting events, JTB offers support for a wide spectrum of travel-related activities. Guided by its vision "Perfect moments, always," JTB is committed to delivering personalized experiences to individuals, businesses and institutions worldwide. With a global presence spanning 152 locations across 36 countries & regions, JTB seamlessly connects people, places and possibilities, all while fostering a sustainable future. https://www.jtbcorp.jp/en/

View source version on businesswire.com: https://www.businesswire.com/news/home/20260203174455/en/

Contacts

Contact for press inquiries:
JTB Corp. Public Relations team
E-mail: jtb0074_all@jtb.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye